Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Compare index funds with the lowest expense ratios for retirement in 2024 to minimize fees while pursuing solid returns. Find your top pick today.
27,341 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Robinhood Chain has posted $816,000 in gross revenue since its July 1 launch, with 89% going to Robinhood, 10% to Arb...
Nebius shares fell about 13% in afternoon trading as the neocloud trade shows renewed pressure on asset-light AI clou...
A major stake from Nvidia lit a fire under Nebius Group, sending Nebius stock soared today. Here's what this means fo...
Tori Spelling says her California rental, home to five children, costs $12,000 a month and feels chaotic. The remark ...
This analysis unpacks Interface (Tile)'s Q4 2025 earnings, translating numbers into a practical view for investors. L...
Axon Enterprise stock soared higher after a solid earnings beat and a ambitious revenue goal. This article breaks dow...
WTRG just released its quarterly earnings, and the market is parsing revenue growth, margins, and forward guidance. T...
Analysts warn that electrifying AI data centers by 2030 could require $1.4 trillion in investment, driven by surging ...
This deep dive breaks down AKA Brands' 2025 Q4 results. Learn what the numbers mean for the business, where growth ca...
United Wholesale Mortgage's parent raises its 2026 revenue forecast just before a key Two Harbors Investment vote on ...
Arm Holdings sits at the crossroads of mobile silicon and AI at the edge. This article lays out why edge AI could ext...